SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-21-000029
Filing Date
2021-11-09
Accepted
2021-11-09 16:22:13
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx-20210930.htm   iXBRL 10-Q 1639855
2 EX-10.1 exhibit101redacted.htm EX-10.1 414893
3 EX-10.2 ex102eagle-aoplicenseagree.htm EX-10.2 357459
4 EX-31.1 exhibit311q32021.htm EX-31.1 8484
5 EX-31.2 exhibit312q32021.htm EX-31.2 8443
6 EX-32.1 exhibit321q32021.htm EX-32.1 9050
  Complete submission text file 0000827871-21-000029.txt   8547095

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20210930.xsd EX-101.SCH 38746
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20210930_cal.xml EX-101.CAL 113476
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20210930_def.xml EX-101.DEF 180834
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20210930_lab.xml EX-101.LAB 603980
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20210930_pre.xml EX-101.PRE 379365
12 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20210930_htm.xml XML 1435179
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 211392535
SIC: 2834 Pharmaceutical Preparations